MAPK3 and neoplasm: The ERK1/2 phosphorylation induced by treatment with isoproterenol was insufficient to increase the ERK1/2 phosphorylation and mo-MDSCs generation in CXCR2−/− tumor-bearing mice as shown in WT tumor-bearing mice (Fig. S5A−D).